Novozymes (NVZMY)
(Delayed Data from OTC)
$65.19 USD
+0.20 (0.31%)
Updated Aug 1, 2025 03:59 PM ET
1-Strong Buy of 5 1
F Value D Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Novozymes A/S has a PEG ratio of 3.79 compared to the Chemical - Specialty industry's PEG ratio of 2.39.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NVZMY 65.19 +0.20(0.31%)
Will NVZMY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NVZMY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVZMY
Has Harmony Gold (HMY) Outpaced Other Basic Materials Stocks This Year?
Novozymes (NVZMY) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
NVZMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Basic Materials Stocks Lagging Iamgold (IAG) This Year?
Is Novozymes (NVZMY) Stock Outpacing Its Basic Materials Peers This Year?
Best Income Stocks to Buy for May 14th
Other News for NVZMY
Novonesis (NVZMY) Target Price Upgraded by Berenberg Analyst | NVZMY Stock News
Novonesis price target raised to DKK 530 from DKK 510 at Berenberg
Novonesis price target raised by DKK 20 at Berenberg
Jefferies Sticks to Their Buy Rating for Novonesis (0Q4U)
Kepler Capital Remains a Hold on Novonesis (0Q4U)